Delivery Order SPE2DE21D7010-SPE2D626F20F6
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $1,956.60 delivery order (Contract No. 4570300075) by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, for the supply of MAXCESS spinal surgical products. The contract utilizes a fixed-price pricing structure with economic price adjustment mechanisms and carries no set-aside designation, reflecting successful competition in open market procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of January 6, 2026. The contract is structured as a firm fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting the company's competitive standing in open market federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 28, 2025, with an ultimate completion date of January 5, 2026. This fixed-price delivery order with economic price adjustment mechanism is for MAXCESS spinal surgical products and related medical technologies. The award was issued under an open market competitive procurement with no set-aside designation, reflecting...
- Nuvasive, Inc. has been awarded a $37,861.56 delivery order by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency supporting Department of Defense and Veterans Affairs healthcare operations. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 18, 2025, and involves the delivery of specialized spinal medical technologies and surgical equipment to support military and veteran healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order (Contract No. 4570300073) valued at $2,009.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025. The contract covers the delivery of MAXCESS spinal surgical products and related medical devices to support Department of Defense and Department of Veterans Affairs healthcare operations. Structured as a firm...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $4,346 fixed-price delivery order with economic price adjustment (FPEA) by the Defense Logistics Agency (DLA) Medical Supply Chain on November 26, 2025, with a completion date of January 5, 2026. This delivery order, issued without set-aside designation, represents a competitive open-market procurement for specialized spinal surgical products and services to support...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $1,681.90 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 24, 2025. This fixed-price contract with economic price adjustment mechanisms is set to be completed by July 25, 2025. The award represents an open market procurement with no set-aside designation, consistent with Nuvasive's established competitive success in federal healthcare...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F20F6Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., has been awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency (DLA) Medical Supply Chain for the MAXCESS spinal surgical product. The contract, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, employs a fixed-price structure with economic price adjustment provisions. This award carries no set-aside designation, reflecting Nuvasive's competitive standing in open market federal procurements. The DLA Medical Supply Chain procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities, and this delivery order supports the specialized spinal surgical capabilities required across military and veteran healthcare systems. This delivery order is issued against Nuvasive's broader relationship with the federal healthcare enterprise, including participation in Transplant Technology Inc.'s $8 million Blanket Purchase Agreement with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027. Nuvasive has established itself as a critical supplier to the Department of Defense and Department of Veterans Affairs through consistent delivery of advanced spinal fusion devices, interbody implants, bone graft materials, and specialized surgical instruments. The company's product portfolio and contract history demonstrate sustained capability in delivering orthopedic and neurosurgical technologies that directly support operational readiness and medical mission effectiveness across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/11/25 |